Hughes, The Journal of the American Medical Association vol. 305 no. February 22, 2011 1027-1028.
A commentary in JAMA by IDSA President James Hughes, MD, FIDSA (subscription required).
IDSA, Clinical Infectious Diseases vol. 50 no. 8 April 15, 2010 1081-1083.
IDSA and other organizations call for a global commitment to develop 10 new systemic antibiotics by 2020.
Boucher et al., Clinical Infectious Diseases vol. 48 no. 1 January 1, 2009
IDSA expresses concern about the lean pipeline for novel therapeutics to treat drug-resistant infections, especially those caused by gram-negative pathogens.
Spellberg et al., Clinical Infectious Diseases vol. 46 no. 2 January 15, 2008 155-164.
A call to action for the medical community from the Infectious Diseases Society of America.
Talbot et al., Clinical Infectious Diseases vol. 42 no. 5 March 1, 2006.
An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2016 Infectious Diseases Society of America